Bogdan Czerniak

Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis

K. Baggerly, Tadeusz Majewski, J. Bondaruk, 2024, Cell reports.

Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer

E. Batourina, H. Al-Ahmadie, A. Viny, 2024, Nature communications.

METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics

A. Jazaeri, Guangchun Han, F. Peng, 2023, bioRxiv.